drugset / Trial / NCT04972123

The Effect of CPC on Aborting Tilt Induced Syncope in Patients With a History of Vasovagal Syncope or Near Syncope

NCT04972123

Phase 2 Completed 143 enrolled University of Wisconsin, Madison
RandomizedParallel-groupTriple-blindTreatment

Summary

Syncope is defined as transient loss of consciousness associated with inability to maintain postural tone with rapid and spontaneous recovery. The purpose of this study is to assess the effects of sublingual administration of a new medication called CPC on tilt-induced syncope in patients with a history of vasovagal syncope (VVS) or near syncope. 140 participants will be randomized at the University of Wisconsin - Madison. Each participant will be in the study for 1 day.

Timeline

Start
2021-07-20
Primary completion
2023-08-25
Completion
2023-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule Subcutaneous
Subject Capsaicin Small molecule Subcutaneous
Subject Phenylephrine Small molecule Subcutaneous